75/100B47.010
USD
0.10
(0.21%)
Pre Open·48.030USD+1.020(+2.17%)
Last updated: · Delayed 15 min
Fair value82.55Plus-43%62Price 47.01103
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Sanofi ADS price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
Sanofi ADS's P/S ratio is 1.99: its market cap of 101.54B EUR over revenue of 50.98B EUR in the last twelve months.
- Today
- 1.99
- Average, 5 years
- 2.50
- Low, 5 years
- 1.64
- High, 5 years
- 3.35
P/S ratio = market cap ÷ revenue (last 12 months) = 101.54B ÷ 50.98B = 1.99
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 1.99 | 101.54B | 50.98B | |
| FY2025 | 31 Dec 2025 | 2.15 | 100.67B | 46.72B |
| FY2024 | 31 Dec 2024 | 2.63 | 116.57B | 44.29B |
| FY2023 | 31 Dec 2023 | 2.71 | 112.63B | 41.62B |
| FY2022 | 31 Dec 2022 | 2.79 | 113.24B | 40.56B |
| FY2021 | 31 Dec 2021 | 2.82 | 110.37B | 39.18B |
| FY2020 | 31 Dec 2020 | 2.67 | 99.68B | 37.37B |
| FY2019 | 31 Dec 2019 | 2.97 | 111.90B | 37.63B |
| FY2018 | 31 Dec 2018 | 2.65 | 94.41B | 35.68B |
| FY2017 | 31 Dec 2017 | 2.49 | 90.04B | 36.22B |
| FY2016 | 31 Dec 2016 | 2.85 | 98.82B | 34.70B |
| FY2015 | 31 Dec 2015 | 2.94 | 102.59B | 34.86B |
| FY2014 | 31 Dec 2014 | 3.10 | 99.18B | 32.00B |
| FY2013 | 31 Dec 2013 | 3.30 | 103.17B | 31.29B |
| FY2012 | 31 Dec 2012 | 2.64 | 94.75B | 35.96B |
| FY2011 | 31 Dec 2011 | 2.13 | 74.54B | 35.06B |
| FY2010 | 31 Dec 2010 | 1.85 | 62.84B | 34.04B |
| FY2009 | 31 Dec 2009 | 2.33 | 71.60B | 30.75B |
| FY2008 | 31 Dec 2008 | 2.09 | 60.31B | 28.82B |
| FY2007 | 31 Dec 2007 | 2.88 | 84.03B | 29.21B |
| FY2006 | 31 Dec 2006 | 3.20 | 94.23B | 29.49B |
| FY2005 | 31 Dec 2005 | 3.48 | 99.02B | 28.49B |
| FY2004 | 31 Dec 2004 | 3.42 | 53.80B | 15.72B |
| FY2003 | 31 Dec 2003 | 5.25 | 42.14B | 8.03B |
| FY2002 | 31 Dec 2002 | 5.66 | 42.16B | 7.46B |
| FY2001 | 31 Dec 2001 | 7.55 | 48.98B | 6.49B |
| FY2000 | 31 Dec 2000 | 7.75 | 46.21B | 5.96B |
| FY1999 | 31 Dec 1999 | 8.08 | 43.24B | 5.35B |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 1.71 | 87.31B | 50.98B |
| Q2 FY2026 | 30 Jun 2026 | 1.83 | 89.36B | 48.92B |
| Q1 FY2026 | 31 Mar 2026 | 2.12 | 100.38B | 47.35B |
| Q4 FY2025 | 31 Dec 2025 | 2.15 | 100.67B | 46.72B |
| Q3 FY2025 | 30 Sept 2025 | 2.32 | 97.97B | 42.14B |
| Q2 FY2025 | 30 Jun 2025 | 2.35 | 101.16B | 43.13B |
| Q1 FY2025 | 31 Mar 2025 | 2.89 | 126.48B | 43.77B |
| Q4 FY2024 | 31 Dec 2024 | 2.72 | 116.77B | 42.89B |
| Q3 FY2024 | 30 Sept 2024 | 2.73 | 129.68B | 47.46B |
| Q2 FY2024 | 30 Jun 2024 | 2.51 | 115.60B | 46.01B |
| Q1 FY2024 | 31 Mar 2024 | 2.48 | 112.23B | 45.31B |
| Q4 FY2023 | 31 Dec 2023 | 2.43 | 112.80B | 46.44B |
| Q3 FY2023 | 30 Sept 2023 | 2.78 | 127.12B | 45.70B |
| Q2 FY2023 | 30 Jun 2023 | 2.68 | 123.56B | 46.14B |
| Q1 FY2023 | 31 Mar 2023 | 2.71 | 125.37B | 46.20B |
| Q4 FY2022 | 31 Dec 2022 | 2.50 | 113.43B | 45.39B |
| Q3 FY2022 | 30 Sept 2022 | 2.19 | 97.27B | 44.35B |
| Q2 FY2022 | 30 Jun 2022 | 2.84 | 119.41B | 42.04B |
| Q1 FY2022 | 31 Mar 2022 | 2.87 | 115.86B | 40.34B |
| Q4 FY2021 | 31 Dec 2021 | 2.82 | 110.58B | 39.18B |
| Q3 FY2021 | 30 Sept 2021 | 2.71 | 104.46B | 38.50B |
| Q2 FY2021 | 30 Jun 2021 | 2.96 | 111.14B | 37.55B |
| Q1 FY2021 | 31 Mar 2021 | 2.85 | 105.34B | 36.94B |
| Q4 FY2020 | 31 Dec 2020 | 2.67 | 99.68B | 37.37B |
| Q3 FY2020 | 30 Sept 2020 | 2.85 | 107.44B | 37.65B |
| Q2 FY2020 | 30 Jun 2020 | 3.02 | 113.93B | 37.69B |
| Q1 FY2020 | 31 Mar 2020 | 2.59 | 99.22B | 38.23B |
| Q4 FY2019 | 31 Dec 2019 | 2.98 | 112.19B | 37.63B |
| Q3 FY2019 | 30 Sept 2019 | 2.88 | 106.44B | 36.94B |
| Q2 FY2019 | 30 Jun 2019 | 2.62 | 96.39B | 36.76B |
| Q1 FY2019 | 31 Mar 2019 | 2.72 | 98.50B | 36.26B |
| Q4 FY2018 | 31 Dec 2018 | 2.64 | 94.30B | 35.68B |
| Q3 FY2018 | 30 Sept 2018 | 2.74 | 96.91B | 35.33B |
| Q2 FY2018 | 30 Jun 2018 | 2.44 | 85.40B | 34.98B |
| Q1 FY2018 | 31 Mar 2018 | 2.29 | 81.17B | 35.43B |
| Q4 FY2017 | 31 Dec 2017 | 2.48 | 89.76B | 36.20B |
| Q3 FY2017 | 30 Sept 2017 | 2.90 | 105.68B | 36.40B |
| Q2 FY2017 | 30 Jun 2017 | 2.90 | 105.44B | 36.30B |
| Q1 FY2017 | 31 Mar 2017 | 3.00 | 107.08B | 35.68B |
| Q4 FY2016 | 31 Dec 2016 | 2.84 | 98.53B | 34.71B |
| Q3 FY2016 | 30 Sept 2016 | 2.70 | 87.52B | 32.36B |
| Q2 FY2016 | 30 Jun 2016 | 2.96 | 96.98B | 32.75B |
| Q1 FY2016 | 31 Mar 2016 | 2.74 | 90.89B | 33.20B |
| Q4 FY2015 | 31 Dec 2015 | 3.06 | 102.49B | 33.49B |
| Q3 FY2015 | 30 Sept 2015 | 3.10 | 110.91B | 35.83B |
| Q2 FY2015 | 30 Jun 2015 | 3.31 | 116.05B | 35.02B |
| Q1 FY2015 | 31 Mar 2015 | 3.50 | 120.42B | 34.40B |
| Q4 FY2014 | 31 Dec 2014 | 2.91 | 99.18B | 34.11B |
| Q3 FY2014 | 30 Sept 2014 | 3.50 | 117.29B | 33.48B |
| Q2 FY2014 | 30 Jun 2014 | 3.08 | 102.04B | 33.13B |
| Q1 FY2014 | 31 Mar 2014 | 3.03 | 100.15B | 33.07B |
| Q4 FY2013 | 31 Dec 2013 | 3.09 | 103.02B | 33.31B |
| Q3 FY2013 | 30 Sept 2013 | 2.96 | 99.08B | 33.42B |
| Q2 FY2013 | 30 Jun 2013 | 3.07 | 104.80B | 34.15B |
| Q1 FY2013 | 31 Mar 2013 | 2.99 | 105.23B | 35.18B |
| Q4 FY2012 | 31 Dec 2012 | 2.64 | 94.85B | 35.96B |
| Q3 FY2012 | 30 Sept 2012 | 2.48 | 89.93B | 36.22B |
| Q2 FY2012 | 30 Jun 2012 | 2.17 | 78.55B | 36.15B |
| Q1 FY2012 | 31 Mar 2012 | 2.14 | 76.73B | 35.80B |
| Q4 FY2011 | 31 Dec 2011 | 2.14 | 75.04B | 35.06B |
| Q3 FY2011 | 30 Sept 2011 | 1.93 | 65.62B | 33.95B |
| Q2 FY2011 | 30 Jun 2011 | 2.22 | 73.27B | 33.03B |
| Q1 FY2011 | 31 Mar 2011 | 2.00 | 64.85B | 32.45B |
| Q4 FY2010 | 31 Dec 2010 | 1.96 | 62.90B | 32.04B |
| Q3 FY2010 | 30 Sept 2010 | 2.00 | 63.80B | 31.95B |
| Q2 FY2010 | 30 Jun 2010 | 2.04 | 64.26B | 31.47B |
| Q1 FY2010 | 31 Mar 2010 | 2.33 | 72.27B | 31.07B |
| Q4 FY2009 | 31 Dec 2009 | 2.33 | 71.62B | 30.75B |
| Q3 FY2009 | 30 Sept 2009 | 2.16 | 65.91B | 30.48B |
| Q2 FY2009 | 30 Jun 2009 | 1.84 | 54.87B | 29.87B |
| Q1 FY2009 | 31 Mar 2009 | 1.89 | 55.01B | 29.18B |
| Q4 FY2008 | 31 Dec 2008 | 2.09 | 60.20B | 28.82B |
| Q3 FY2008 | 30 Sept 2008 | 2.06 | 60.74B | 29.53B |
| Q2 FY2008 | 30 Jun 2008 | 1.89 | 55.39B | 29.33B |
| Q1 FY2008 | 31 Mar 2008 | 2.13 | 62.87B | 29.56B |
| Q4 FY2007 | 31 Dec 2007 | 2.82 | 83.21B | 29.52B |
| Q3 FY2007 | 30 Sept 2007 | 2.78 | 79.88B | 28.74B |
| Q2 FY2007 | 30 Jun 2007 | 2.76 | 80.31B | 29.13B |
| Q1 FY2007 | 31 Mar 2007 | 3.01 | 88.02B | 29.24B |
| Q4 FY2006 | 31 Dec 2006 | 3.20 | 94.39B | 29.51B |
| Q3 FY2006 | 30 Sept 2006 | 3.22 | 95.00B | 29.46B |
| Q2 FY2006 | 30 Jun 2006 | 3.46 | 102.34B | 29.62B |
| Q1 FY2006 | 31 Mar 2006 | 3.63 | 105.28B | 28.99B |
| Q4 FY2005 | 31 Dec 2005 | 3.51 | 99.31B | 28.32B |
| Q3 FY2005 | 30 Sept 2005 | 3.51 | 92.24B | 26.31B |
| Q2 FY2005 | 30 Jun 2005 | 3.75 | 90.42B | 24.13B |
| Q1 FY2005 | 31 Mar 2005 | 4.43 | 87.16B | 19.67B |
| Q4 FY2004 | 31 Dec 2004 | 3.11 | 47.47B | 15.24B |
| Q3 FY2004 | 30 Sept 2004 | 3.51 | 40.99B | 11.69B |
| Q2 FY2004 | 30 Jun 2004 | 4.08 | 35.82B | 8.77B |
| Q1 FY2004 | 31 Mar 2004 | 4.65 | 38.88B | 8.36B |
| Q4 FY2003 | 31 Dec 2003 | 5.33 | 43.04B | 8.08B |
| Q3 FY2003 | 30 Sept 2003 | 4.46 | 36.60B | 8.20B |
| Q2 FY2003 | 30 Jun 2003 | 4.68 | 35.80B | 7.65B |
| Q1 FY2003 | 31 Mar 2003 | 4.37 | 32.95B | 7.54B |
| Q4 FY2002 | 31 Dec 2002 | — | 41.48B | — |
| Q3 FY2002 | 30 Sept 2002 | — | 41.62B | — |
| Q2 FY2002 | 30 Jun 2002 | — | 43.95B | — |
Figures in EUR. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Sanofi ADS's P/S ratio
Source: Financial Modeling Prep